Devazepide
Exploratory indications related to gastrointestinal motility and appetite regulation
- CAS No.
- 103420-77-5
- Indication Class
- Gastroenterology / Hepatology
- Patent Expiry
- Off-patent · 2020 (to verify)
- Therapeutic Area
- Gastroenterology / Metabolism
- Labeled Purity
- 99+%
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- Confirm per inquiry
- Patent Scope
- 1990s compound patent; expired per 20-yr term estimate — to be verified
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higherNo intermediate entries are on file for this API yet. You can still enquire by CAS number — we will route it to the supply side for manual sourcing.
Listing Logic · Why It's Worth Listing
A classic cholecystokinin-receptor antagonist research molecule, commonly used in basic studies of digestion physiology and appetite regulation.
Gastroenterology / Metabolism · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
Intermediates confirmed per inquiry
Product Description
Devazepide is a CCK-A receptor antagonist primarily used to assist in the study of appetite, digestion, and gut brain axis mechanisms.
Supply source: Unibest · Devazepide, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.